by admin | Apr 4, 2019 | Cognition Therapeutic, News
Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative diseases and disorders caused by membrane trafficking dysfunction, today announced that Mary Sano, Ph.D. of Mount...
by admin | Feb 19, 2019 | Cognition Therapeutic, News
Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cognitive Improvement Pittsburgh, Feb. 19, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and...
by admin | Jan 18, 2019 | Cognition Therapeutic, News
While the “War on Cancer” has made significant progress, the “War on Alzheimer’s” has proven to be a seemingly implacable foe. The societal costs of neurodegenerative diseases are enormous – Alzheimer’s disease is the most common cognitive dementia, affecting one of...
by admin | Dec 20, 2018 | Cariloop, News
For the past four years, Entrepreneur magazine has conducted a nationwide search to find the most entrepreneurial companies in the country, rating and ranking them using a proprietary algorithm that factors in their ability to expertly balance impact, innovation,...
by admin | Dec 19, 2018 | Encore Vision, News
Novartis has revealed how much it paid to buy Encore Vision, a Fort Worth startup that has developed an eyedrop to treat presbyopia — and it’s an eye-opener. In an SEC filing Wednesday, the Swiss pharmaceutical giant that owns Alcon put the preliminary fair value of...
by admin | Dec 5, 2018 | Cariloop, News
Employee Benefits News speaks to HR leaders and Benefits Specialists around the world on why it doesn’t matter what your workforce looks like, you have employee caregivers who need help. This article features Cariloop’s CEO, Michael Walsh, discussing the impact of...
